Cargando…

Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer

SIMPLE SUMMARY: Gastric cancer (GC) accounts for a considerable amount of morbidity and mortality worldwide. This study developed and experimentally validated a prognostic risk gene signature (PRGS). This is a stable and robust signature for assessing the prognosis of gastric cancer. We performed mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chengcheng, Huo, Yuying, Zhang, Yansong, Yin, Fumei, Chen, Taoyu, Wang, Zhenyi, Gao, Juntao, Jin, Peng, Li, Xiangyu, Shi, Minglei, Zhang, Michael Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000504/ https://www.ncbi.nlm.nih.gov/pubmed/36900401 http://dx.doi.org/10.3390/cancers15051610

Ejemplares similares

Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer
por: Zhang, Fan, et al.
Publicado: (2021)

Immune landscape and prognostic gene signatures in gastric cancer: implications for cachexia and clinical outcomes
por: Sui, Xiangyu, et al.
Publicado: (2023)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

Identification and verification of a glycolysis-related gene signature for gastric cancer
por: Liu, Yi, et al.
Publicado: (2022)

Prognostic Value of microRNA Signature in Patients with Gastric Cancers
por: Liu, Hai-Ting, et al.
Publicado: (2017)

Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients
por: Zhu, Minggu, et al.
Publicado: (2018)

Identification and validation of a prognostic 9-genes expression signature for gastric cancer
por: Wang, Zhiqiang, et al.
Publicado: (2017)

Development and validation of metabolism-related gene signature in prognostic prediction of gastric cancer
por: Luo, Tianqi, et al.
Publicado: (2020)

Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
por: Cheong, Jae-Ho, et al.
Publicado: (2022)

Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages
por: Huo, Junyu, et al.
Publicado: (2021)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)

Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
por: Wu, Pu, et al.
Publicado: (2021)

Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer
por: Yu, Jing, et al.
Publicado: (2022)

Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis and experimental validation
por: Zhang, Nana, et al.
Publicado: (2019)

Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma
por: Ju, Gaoda, et al.
Publicado: (2022)

Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer
por: Peng, Dongzhu, et al.
Publicado: (2020)

Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer
por: Chen, Shimin, et al.
Publicado: (2021)

Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
por: Wang, Qian, et al.
Publicado: (2022)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

Computational Screening of Phase-separating Proteins
por: Shen, Boyan, et al.
Publicado: (2021)

Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy
por: Gong, Qianwen, et al.
Publicado: (2020)

Integrative analysis of cancer-associated fibroblast signature in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

CBXs-related prognostic gene signature correlates with immune microenvironment in gastric cancer
por: Zhang, Yin Jiang, et al.
Publicado: (2022)

Systematic Review of Prognostic Gene Signature in Gastric Cancer Patients
por: Xie, Longxiang, et al.
Publicado: (2020)

Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma
por: Chen, Jialu, et al.
Publicado: (2022)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer
por: Huo, Junyu, et al.
Publicado: (2022)

Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma
por: Shi, Ke, et al.
Publicado: (2022)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer
por: Cao, Xueyan, et al.
Publicado: (2022)

The Construction of a Prognostic Model Based on a Peptidyl Prolyl Cis–Trans Isomerase Gene Signature in Hepatocellular Carcinoma
por: Shi, Huadi, et al.
Publicado: (2021)

Integration of single cell data by disentangled representation learning
por: Guo, Tiantian, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hn1h7tl74q1e58jnaigml2gdu2